BCG
ABBV icon

Breakwater Capital Group’s AbbVie ABBV Stock Holding History

Breakwater Capital Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Sell
5,987
-293
-5% -$63K 0.18% 127
2026
Q1 		$1.37M Buy
6,280
+232
+4% +$51.5K 0.18% 127
2025
Q4 		$1.38M Sell
6,048
-102
-2% -$23.2K 0.19% 113
2025
Q3 		$1.42M Buy
6,150
+130
+2% +$26.5K 0.21% 106
2025
Q2 		$1.12M Buy
6,020
+216
+4% +$40.1K 0.18% 119
2025
Q1 		$1.22M Buy
5,804
+783
+16% +$152K 0.22% 104
2024
Q4 		$892K Buy
5,021
+492
+11% +$90.5K 0.18% 122
2024
Q3 		$894K Buy
4,529
+85
+2% +$15.9K 0.18% 117
2024
Q2 		$762K Sell
4,444
-50
-1% -$8.28K 0.17% 127
2024
Q1 		$818K Buy
4,494
+543
+14% +$93.6K 0.21% 107
2023
Q4 		$653K Buy
3,951
+597
+18% +$87K 0.18% 107
2023
Q3 		$478K Buy
3,354
+375
+13% +$55.1K 0.16% 119
2023
Q2 		$401K Buy
2,979
+161
+6% +$23.6K 0.15% 137
2023
Q1 		$449K Buy
2,818
+204
+8% +$31.2K 0.19% 116
2022
Q4 		$422K Buy
+2,614
New +$401K 0.22% 105

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Breakwater Capital Group's ABBV Position: Q2 2026 in Review

Breakwater Capital Group reduced its AbbVie (ABBV) stake by 4.7% in Q2 2026, selling an estimated $63K and leaving 5,987 shares worth $1.51M. The position accounts for 0.18% of the portfolio, ranked #127.

Breakwater Capital Group first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Breakwater Capital Group held 5,987 shares of AbbVie worth $1.51M as of Q2 2026.
  • Breakwater Capital Group sold 293 AbbVie shares in Q2 2026, an estimated $63K.
  • AbbVie made up 0.18% of Breakwater Capital Group's portfolio in Q2 2026, its #127 holding.
  • Breakwater Capital Group first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Breakwater Capital Group's 13F filing for Q2 2026, filed 8 Jul 2026.